Geographic evidence hub
Published infectious-disease research classified with a high-confidence geographic relationship to Germany.
Evidence stream
20 publications
Infection
Why it matters nowThe authors propose that community-based screening can help identify asymptomatic viral reservoirs and underreported viral circulation, such as adenovirus, linking viral detection to clinical and economic impact.
BMC Infectious Diseases
Why it matters nowThe findings address vaccine-preventable PCC burden in a high-risk age group during the first post-pandemic season and are positioned as input for vaccination policy, communication, and clinical decision-making.
Vaccine
Why it matters nowThe authors present the findings as showing that influenza vaccination coverage remains below target in the groups examined. The study suggests that routine review of vaccination status during outpatient encounters may be an important opportunity for improving uptake in adults with chronic conditions and older adults.
PloS one
Why it matters nowThe authors note that diagnostic evaluation might be warranted for individuals experiencing delayed neurological decline, though the low prevalence limits broad applicability.
The Lancet Infectious Diseases
Why it matters nowThe article provides Germany-specific observational evidence on MVA-BN safety and estimated effectiveness in the population studied during the 2022-2023 mpox period. Its findings may inform editorial context about vaccination evidence, including the reported difference in estimated effectiveness by HIV status, but they do not establish causality or confirm a current surveillance pattern.
Bulletin of the World Health Organization
Why it matters nowThe guideline addressed a critical gap in reliable, globally applicable recommendations for safe and continuous school operations during the COVID-19 pandemic. The WHO-INTEGRATE framework supported transparent, structured decision-making with a whole-of-society perspective on measures to reduce SARS-CoV-2 transmission in schools.
Emerging Microbes & Infections
Why it matters nowThe findings highlight the ongoing zoonotic potential of swine influenza A viruses, as demonstrated by the 2009 human pandemic, and emphasize the importance of pathogen monitoring in pig populations. The emergence of PRV1 and SOV as potential contributors to porcine respiratory disease syndrome may complicate disease control efforts.
Vaccine
Why it matters nowThe registry addresses a recognized barrier in pandemic response by providing a centralized infrastructure to accelerate clinical trial recruitment across European countries, potentially shortening the timeline for vaccine and treatment development during infectious disease outbreaks.
Nature Communications
Why it matters nowThe method addresses practical barriers to pediatric SARS-CoV-2 surveillance by combining non-invasive sample collection with high-throughput capacity. The approach demonstrated feasibility for large-scale infection control in educational settings.
Epidemiology and Infection
Why it matters nowThe findings suggest that mass gathering events can be conducted with limited COVID-19 transmission when health measures for attendees and restrictions on large public viewing are in place. The results underscore the importance of surveillance and public health regulations during mass gatherings.
Nature
Why it matters nowThe study demonstrates that helpline data can provide real-time monitoring of mental health concerns during public health crises, complementing established surveillance approaches. The findings suggest that financial relief measures may mitigate psychological distress associated with lockdown policies.
Nature
Why it matters nowEarly immunogenicity metrics indicate that the formulation triggers complementary defense pathways, positioning it as a candidate tool for future pandemic mitigation strategies pending larger efficacy evaluations.
Vaccine
Why it matters nowHealth worker vaccination addresses dual risks of occupational infection and transmission to vulnerable patients, while also supporting pandemic preparedness. The guidance aims to help countries without policies establish them and to improve low coverage where policies exist.
Vaccine
Why it matters nowNorovirus causes approximately one-fifth of acute gastroenteritis cases globally each year. With vaccines in clinical trials, model-based predictions can inform immunisation policy design and help optimize allocation across age groups depending on whether infection prevention or severe outcome prevention is prioritized.
Eurosurveillance
Why it matters nowDot map cartograms may support outbreak detection and visualization by public health professionals, facilitating informed decisions for investigation and control activities.
Eurosurveillance
Why it matters nowThe report highlights the need for clinicians caring for refugees traversing north Africa to recognise louse-borne relapsing fever, in order to provide timely treatment and apply preventive measures.
Eurosurveillance
Why it matters nowThe report documents the first apparent autochthonous dengue transmission in Croatia, demonstrating the value of cross-border case notification and the role of heightened clinical awareness combined with vector control in detecting and containing local arboviral transmission.
BMC Infectious Diseases
Why it matters nowThe investigation demonstrated food-borne norovirus transmission through contaminated salad at a communal dining facility. Control measures included cohort isolation, exclusion of norovirus-positive food handlers, and kitchen disinfection, emphasizing the importance of strict hygiene and proper environmental disinfection.
Bulletin of the World Health Organization
Why it matters nowThe findings demonstrate ongoing challenges to measles elimination in Germany, highlighting significant immunity gaps in older pediatric age groups that may undermine control strategies.
Clinical Infectious Diseases
Why it matters nowThe findings suggest IGRAs can reduce overdiagnosis and unnecessary treatment of tuberculosis in children by improving specificity, particularly in settings with nontuberculous mycobacterial disease and bacille Calmette-Guerin vaccination.
